Blood thinner use during stroke to predict outcomes
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at how people doing well on certain blood thinners do when they have a stroke or bleeding while taking them. It will measure medication levels in your blood to understand stroke severity and recovery in the short and long term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation (an irregular heart rhythm).
- You are currently taking one of these blood thinners: dabigatran, rivaroxaban, apixaban, or edoxaban.
- You recently had an ischemic stroke, a transient ischemic attack (“mini-stroke”), or an intracranial bleed while on that blood thinner.
- You agree to have blood drawn to measure the blood thinner level in your body.
- You are willing to sign informed consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether the amount of a blood thinner (NOAC) in your bloodstream is linked to health outcomes. It may help doctors better understand how to monitor and use these medicines safely.
This trial studies whether using blood-thinning medicine is safe and appropriate for people after an ischemic stroke who also have small signs of bleeding in the brain. It aims to balance stroke prevention with the risk of bigger bleeding.
This study tests two different blood-thinning medicines to see which is better at preventing another stroke in people who recently had a stroke with no clear cause. The goal is to find a treatment that works well and is safe for you.
This trial tests whether switching to a different type of blood thinner is better than continuing the same type after a stroke. It aims to find the safest way to prevent another stroke in people with atrial fibrillation.
This registry study looks at how people with atrial fibrillation (AF) or blood clots (VTE) use blood thinners, especially NOACs, over time. It may help doctors better understand real-world patterns of treatment and outcomes.
This study tests whether taking a blood thinner after a stroke is safe and helpful for people who have atrial fibrillation (an irregular heartbeat) and have had a bleeding stroke in the past. It aims to prevent future strokes while managing the risk of another brain bleed.
Hear when a new Therapeutic Drug Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.